OncLive - Clinical Oncology News, Cancer Expert Insights
OncLive - Clinical Oncology News, Cancer Expert Insights
Spotlight
OncClub: Join the Chat on Trending Trials in CancerComplimentary print subscription for home or office deliveryIn-person and virtual events just for HCPsLively expert panel discussions featuring peer-to-peer exchangesSubscribe to our eNewsletter for breaking news and curated content
Specialty
View MoreBreast CancerCAR T-cell TherapyChronic Lymphocytic LeukemiaGastrointestinal CancerGenitourinary CancersGynecologic OncologyImmuno-OncologyLung CancerMelanoma & Skin CancerMultiple MyelomaUrothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
Rare Cancer Series
Media
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Thoracic Night Live
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Subscribe
eNewsletter
Print Subscription
  • Advertise
  • About OncLive
  • Editorial Board
  • CancerNetwork.com
  • CGTlive.com
  • CureToday.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information

© 2022 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Spotlight
  • OncClub: Join the Chat on Trending Trials in Cancer
  • Complimentary print subscription for home or office delivery
  • In-person and virtual events just for HCPs
  • Lively expert panel discussions featuring peer-to-peer exchanges
  • Subscribe to our eNewsletter for breaking news and curated content
SpecialtySee All >
  • Breast Cancer
  • CAR T-cell Therapy
  • Chronic Lymphocytic Leukemia
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Gynecologic Oncology
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Multiple Myeloma
  • Urothelial Cancer
OncLive SOSS
  • Advertise
  • About OncLive
  • Editorial Board
  • CancerNetwork.com
  • CGTlive.com
  • CureToday.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
  • MJHLS Brand Logo

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

The New Frontier in NSCLC: Immuno-Oncology Combinations

EP. 1: Implications for Pembrolizumab in NSCLC

June 28th 2018

EP. 2: Pembrolizumab and Chemotherapy in Advanced NSCLC

June 28th 2018

EP. 3: Pembrolizumab: Monotherapy Versus Combination Therapy

June 28th 2018

EP. 4: Metastatic NSCLC: A Look at the IMpower150 Trial

June 28th 2018

EP. 5: Chemotherapy With I-O Therapy in EGFR- or ALK-Mutated NSCLC

June 28th 2018

EP. 6: IPI/NIVO in Metastatic NSCLC

June 28th 2018

EP. 7: Interpreting the Results of CheckMate-227 in NSCLC

June 28th 2018

EP. 8: First-Line Therapy in PD-L1 Advanced NSCLC

June 28th 2018

EP. 9: Baseline Steroid Use in NSCLC

June 28th 2018

EP. 10: Concurrent Chemoradiotherapy in Stage III NSCLC

June 28th 2018

EP. 11: The PACIFIC Trial in Stage 3 NSCLC

June 28th 2018

EP. 12: Implications for Using Durvalumab in Stage 3 NSCLC

June 28th 2018

EP. 13: Neoadjuvant Nivolumab in NSCLC

June 28th 2018

EP. 14: Adjuvant Versus Neoadjuvant Therapy in NSCLC

June 28th 2018

EP. 15: Advanced Squamous NSCLC: The IMpower131 Study

June 28th 2018

EP. 16: Immuno-Oncology in NSCLC: Cost Versus Benefit

June 28th 2018

EP. 17: Emerging Treatment Regimens in Advanced NSCLC

June 28th 2018